NEW YORK (GenomeWeb) – Trovagene said today that it has signed new distribution agreements for its Trovera liquid biopsy tests with seven companies across Europe and the Middle East.
These new strategic partners include Alliance Global for the Middle East, Africa, and Central and South Asia; Instituto Diagnostico and Sorgente Genetica Varelli in Italy; Progenetics in Israel; Amplitech in France, Belgium, and Switzerland; NM Genomix for Bulgaria and Eastern Europe; and Diagnostica Longwood in Spain and Portugal.
According to Trovagene, these partners will introduce the company's clinical tests to physicians, laboratories and cancer centers in their respective regional markets. They will also gain early access to the research-use only liquid biopsy kits and systems Trovagene is co-developing with Boreal Genomics.